Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Operating Expenses | 5,958 | 5,863 | 4,961 | 5,059 | 5,457 |
| Operating Income | -5,958 | -5,863 | -4,961 | -5,059 | -5,457 |
| Other Income | 2,725 | 40,729 | -42,991 | 2,675 | -9,088 |
| Pre-tax Income | -3,233 | 34,866 | -47,952 | -2,384 | -14,545 |
| Net Income Continuous | -3,233 | 34,866 | -47,952 | -2,384 | -14,545 |
| Net Income | $-3,233 | $34,866 | $-47,952 | $-2,384 | $-14,545 |
| EPS Basic Total Ops | -32.19 | 349.90 | -475.86 | -27.99 | -184.74 |
| EPS Basic Continuous Ops | -32.25 | 347.63 | -478.10 | -23.78 | -191.21 |
| EPS Diluted Total Ops | 354.09 | -55.98 | -475.86 | -27.99 | -184.74 |
| EPS Diluted Continuous Ops | 9.61 | 315.13 | -478.10 | -23.78 | -191.21 |
| EBITDA(a) | $-5,951 | $-5,856 | $-4,949 | $-5,042 | $-5,441 |